Young-hee B. Nam

Busan, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Long-Acting Muscarinic Antagonist as an Alternative to Inhaled Corticosteroids in Type 2-Low Mild Asthma: A Randomized Crossover Non-inferiority Trial.

Long-Acting Muscarinic Antagonist as an Alternative to Inhaled Corticosteroids in Type 2-Low Mild Asthma: A Randomized Crossover Non-inferiority Trial.

Journal: The journal of allergy and clinical immunology. In practice

Published: February 25, 2026

Expiratory pulmonary vascular retention on computed tomography as a marker of asthma severity.

Expiratory pulmonary vascular retention on computed tomography as a marker of asthma severity.

Journal: The Journal of allergy and clinical immunology

Published: February 06, 2026

Circulating 1-Methylnicotinamide Predicts Dupilumab Response in Adult Asthma: A Prediction Model.

Circulating 1-Methylnicotinamide Predicts Dupilumab Response in Adult Asthma: A Prediction Model.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: November 02, 2025

Type 2 Biomarkers as Mediators of Clinical Remission With Biologics in Severe Asthma.

Type 2 Biomarkers as Mediators of Clinical Remission With Biologics in Severe Asthma.

Journal: Allergy

Published: October 28, 2025

Immunological Basis of Chronic Spontaneous Urticaria: Immunoglobulin E and Beyond.

Immunological Basis of Chronic Spontaneous Urticaria: Immunoglobulin E and Beyond.

Journal: Yonsei medical journal

Published: September 29, 2025

Asthma remission and its predictors in severe asthma: real-world study from the Korean severe asthma registry.

Asthma remission and its predictors in severe asthma: real-world study from the Korean severe asthma registry.

Journal: Respiratory research

Published: September 25, 2025

Reply to "Optimizing FeNO and blood eosinophil stratification in eosinophilic asthma study: Adjusting for smoking history and blood sampling time".

Reply to "Optimizing FeNO and blood eosinophil stratification in eosinophilic asthma study: Adjusting for smoking history and blood sampling time".

Journal: The journal of allergy and clinical immunology. In practice

Published: August 20, 2025

Siglec-8 as a Biomarker for Predicting Anti-IL-5 Response in Severe Asthma.

Siglec-8 as a Biomarker for Predicting Anti-IL-5 Response in Severe Asthma.

Journal: Allergy, asthma & immunology research

Published: April 05, 2025

Prevalence and Clinical Characteristics of Severe Asthma With Fungal Sensitization in Korea.

Prevalence and Clinical Characteristics of Severe Asthma With Fungal Sensitization in Korea.

Journal: Allergy, asthma & immunology research

Published: February 06, 2025

Concurrent Blood Eosinophils and FeNO as Biological Therapy Indicators in Severe Asthma: Findings From the Precision Medicine Intervention in Severe Asthma Study.

Concurrent Blood Eosinophils and FeNO as Biological Therapy Indicators in Severe Asthma: Findings From the Precision Medicine Intervention in Severe Asthma Study.

Journal: The journal of allergy and clinical immunology. In practice

Published: February 04, 2025

Impact of Biologics on Nasal Symptoms in Severe Asthmatics: Findings From the PRISM Study.

Impact of Biologics on Nasal Symptoms in Severe Asthmatics: Findings From the PRISM Study.

Journal: Allergy, asthma & immunology research

Published: January 08, 2025

Successful dupilumab treatment in a patient with severe dermatitis following allogenic hematopoietic stem cell transplantation.

Successful dupilumab treatment in a patient with severe dermatitis following allogenic hematopoietic stem cell transplantation.

Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology

Published: December 19, 2024

Showing 1-12 of 65

Last Updated: 09/26/2026